Patents by Inventor Valerie Marquardt

Valerie Marquardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210060096
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to stabilize or improve mood, modulate excessive emotional distress, reduce anxiety, and/or reduce stress. In an embodiment, the composition can be administered daily for at least three weeks.
    Type: Application
    Filed: November 17, 2020
    Publication date: March 4, 2021
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Publication number: 20210008130
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 14, 2021
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Patent number: 10821139
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Grant
    Filed: August 31, 2016
    Date of Patent: November 3, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Publication number: 20180250348
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to treat or prevent a depressive symptom. Prolonged anti-depressive effects can continue after administration of the compositions is ended. Non-limiting examples of a depressive symptom which can be treated or prevented include depressed mood; sadness; anxiety; “empty” feelings; loss of interest or pleasure; irritability; restlessness; changes in appetite or weight; sleep disturbances; lack of or decreased energy; feelings of worthlessness; guilt; helplessness; anger and hostility; difficulty in thinking, concentrating, or making decisions; hopelessness; tiredness; fatigue; memory difficulties; tearfulness; brooding; phobias; excessive worry over physical health; sexual dysfunction; persistent physical symptoms that do not respond to treatment; and combinations thereof.
    Type: Application
    Filed: August 31, 2016
    Publication date: September 6, 2018
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt
  • Publication number: 20180250349
    Abstract: Compositions and methods use Bifidobacterium longum NCC3001 (ATCC BAA-999) to stabilize or improve mood, modulate excessive emotional distress, reduce anxiety, and/or reduce stress. In an embodiment, the composition can be administered daily for at least three weeks.
    Type: Application
    Filed: August 31, 2016
    Publication date: September 6, 2018
    Inventors: Gabriela Bergonzelli Degonda, Tiago Alves Nunes, Valerie Marquardt, Jeroen Antonius Johannes Schmitt